Mimes and MRIs, oh my.
[[{"type":"media","view_mode":"media_crop","fid":"49569","attributes":{"alt":"Radiology Comic: Mime Problems","class":"media-image","id":"media_crop_1862611351299","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6004","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.